Technology Distributors
Compare Stocks
5 / 10Stock Comparison
IZM vs LIQT vs CODA vs CLPS vs ACMR
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Pollution & Treatment Controls
Aerospace & Defense
Information Technology Services
Semiconductors
IZM vs LIQT vs CODA vs CLPS vs ACMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Technology Distributors | Industrial - Pollution & Treatment Controls | Aerospace & Defense | Information Technology Services | Semiconductors |
| Market Cap | $1M | $22M | $134M | $25M | $3.92B |
| Revenue (TTM) | $362M | $17M | $28M | $299M | $901M |
| Net Income (TTM) | $-667K | $-9M | $4M | $-4M | $94M |
| Gross Margin | 2.8% | 4.9% | 66.3% | 22.8% | 44.4% |
| Operating Margin | -0.2% | -50.0% | 17.4% | -1.4% | 12.1% |
| Forward P/E | — | — | 22.5x | — | 29.7x |
| Total Debt | $12M | $12M | $395K | $34M | $303M |
| Cash & Equiv. | $2M | — | $29M | $28M | $766M |
IZM vs LIQT vs CODA vs CLPS vs ACMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 23 | May 26 | Return |
|---|---|---|---|
| ICZOOM Group Inc. (IZM) | 100 | 22.2 | -77.8% |
| LiqTech Internation… (LIQT) | 100 | 61.4 | -38.6% |
| Coda Octopus Group,… (CODA) | 100 | 162.6 | +62.6% |
| CLPS Incorporation (CLPS) | 100 | 80.9 | -19.1% |
| ACM Research, Inc. (ACMR) | 100 | 506.0 | +406.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IZM vs LIQT vs CODA vs CLPS vs ACMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IZM lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, LIQT doesn't own a clear edge in any measured category.
CODA carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 30.7%, EPS growth 15.6%, 3Y rev CAGR 6.1%
- Lower volatility, beta 1.00, Low D/E 0.7%, current ratio 8.86x
- 30.7% revenue growth vs IZM's -17.0%
- Better valuation composite
CLPS is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 3 yrs, beta 0.27, yield 14.6%
- Beta 0.27, yield 14.6%, current ratio 1.58x
- Beta 0.27 vs ACMR's 3.24
- 14.6% yield, 3-year raise streak, vs ACMR's 0.2%, (3 stocks pay no dividend)
ACMR ranks third and is worth considering specifically for long-term compounding and valuation efficiency.
- 30.7% 10Y total return vs CODA's 8.4%
- PEG 0.84 vs CODA's 5.24
- +195.6% vs IZM's -81.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 30.7% revenue growth vs IZM's -17.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 14.8% margin vs LIQT's -53.3% | |
| Stability / Safety | Beta 0.27 vs ACMR's 3.24 | |
| Dividends | 14.6% yield, 3-year raise streak, vs ACMR's 0.2%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +195.6% vs IZM's -81.6% | |
| Efficiency (ROA) | 6.6% ROA vs LIQT's -29.5%, ROIC 11.2% vs -31.1% |
IZM vs LIQT vs CODA vs CLPS vs ACMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IZM vs LIQT vs CODA vs CLPS vs ACMR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CODA leads in 2 of 6 categories
IZM leads 1 • ACMR leads 1 • CLPS leads 1 • LIQT leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CODA leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ACMR is the larger business by revenue, generating $901M annually — 53.7x LIQT's $17M. CODA is the more profitable business, keeping 14.8% of every revenue dollar as net income compared to LIQT's -53.3%. On growth, LIQT holds the edge at +53.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $362M | $17M | $28M | $299M | $901M |
| EBITDAEarnings before interest/tax | $184,236 | -$6M | $6M | -$1M | $126M |
| Net IncomeAfter-tax profit | -$666,903 | -$9M | $4M | -$4M | $94M |
| Free Cash FlowCash after capex | $2M | -$7M | $7M | $0 | -$69M |
| Gross MarginGross profit ÷ Revenue | +2.8% | +4.9% | +66.3% | +22.8% | +44.4% |
| Operating MarginEBIT ÷ Revenue | -0.2% | -50.0% | +17.4% | -1.4% | +12.1% |
| Net MarginNet income ÷ Revenue | -0.2% | -53.3% | +14.8% | -1.3% | +10.4% |
| FCF MarginFCF ÷ Revenue | +0.4% | -39.3% | +24.6% | -2.3% | -7.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.0% | +53.6% | +28.8% | +15.3% | +9.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.0% | +69.4% | +3.0% | +75.8% | -76.1% |
Valuation Metrics
IZM leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 32.2x trailing earnings, CODA trades at a 26% valuation discount to ACMR's 43.2x P/E. Adjusting for growth (PEG ratio), ACMR offers better value at 1.22x vs CODA's 7.51x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1M | $22M | $134M | $25M | $3.9B |
| Enterprise ValueMkt cap + debt − cash | $11M | $34M | $106M | $31M | $3.5B |
| Trailing P/EPrice ÷ TTM EPS | -1.74x | -2.59x | 32.16x | -3.48x | 43.21x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 22.45x | — | 29.68x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 7.51x | — | 1.22x |
| EV / EBITDAEnterprise value multiple | — | — | 17.85x | — | 27.49x |
| Price / SalesMarket cap ÷ Revenue | 0.01x | 1.35x | 5.05x | 0.15x | 4.35x |
| Price / BookPrice ÷ Book value/share | 0.26x | 2.14x | 2.30x | 0.43x | 2.06x |
| Price / FCFMarket cap ÷ FCF | 0.76x | — | 22.20x | — | — |
Profitability & Efficiency
CODA leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
CODA delivers a 7.2% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-70 for LIQT. CODA carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to LIQT's 1.17x. On the Piotroski fundamental quality scale (0–9), CODA scores 7/9 vs ACMR's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.3% | -70.0% | +7.2% | -6.1% | +6.1% |
| ROA (TTM)Return on assets | -1.5% | -29.5% | +6.6% | -3.2% | +3.9% |
| ROICReturn on invested capital | -4.1% | -31.1% | +11.2% | -7.9% | +7.0% |
| ROCEReturn on capital employed | -8.6% | — | +8.1% | -9.8% | +6.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 2 | 7 | 2 | 2 |
| Debt / EquityFinancial leverage | 0.79x | 1.17x | 0.01x | 0.59x | 0.16x |
| Net DebtTotal debt minus cash | $10M | $12M | -$28M | $6M | -$463M |
| Cash & Equiv.Liquid assets | $2M | — | $29M | $28M | $766M |
| Total DebtShort + long-term debt | $12M | $12M | $394,932 | $34M | $303M |
| Interest CoverageEBIT ÷ Interest expense | -0.31x | -13.46x | — | — | 20.44x |
Total Returns (Dividends Reinvested)
ACMR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ACMR five years ago would be worth $23,344 today (with dividends reinvested), compared to $391 for LIQT. Over the past 12 months, ACMR leads with a +195.6% total return vs IZM's -81.6%. The 3-year compound annual growth rate (CAGR) favors ACMR at 80.5% vs IZM's -47.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -85.1% | +54.9% | +25.1% | -10.3% | +31.9% |
| 1-Year ReturnPast 12 months | -81.6% | +64.8% | +78.9% | -5.4% | +195.6% |
| 3-Year ReturnCumulative with dividends | -85.9% | -31.3% | +34.5% | +0.5% | +487.9% |
| 5-Year ReturnCumulative with dividends | -88.4% | -96.1% | +49.7% | -69.3% | +133.4% |
| 10-Year ReturnCumulative with dividends | -88.4% | -90.9% | +844.4% | -78.5% | +3065.8% |
| CAGR (3Y)Annualised 3-year return | -47.9% | -11.8% | +10.4% | +0.2% | +80.5% |
Risk & Volatility
Evenly matched — IZM and ACMR each lead in 1 of 2 comparable metrics.
Risk & Volatility
IZM is the less volatile stock with a -0.74 beta — it tends to amplify market swings less than ACMR's 3.24 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ACMR currently trades 82.6% from its 52-week high vs IZM's 14.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.74x | 0.52x | 1.00x | 0.27x | 3.24x |
| 52-Week HighHighest price in past year | $2.74 | $3.35 | $17.28 | $1.88 | $71.65 |
| 52-Week LowLowest price in past year | $0.34 | $1.30 | $5.98 | $0.80 | $19.26 |
| % of 52W HighCurrent price vs 52-week peak | +14.0% | +68.9% | +68.9% | +48.2% | +82.6% |
| RSI (14)Momentum oscillator 0–100 | 41.4 | 57.0 | 48.6 | 49.8 | 60.7 |
| Avg Volume (50D)Average daily shares traded | 2.0M | 50K | 256K | 15K | 1.2M |
Analyst Outlook
CLPS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CODA as "Buy", ACMR as "Buy". Consensus price targets imply 17.6% upside for CODA (target: $14) vs -32.4% for ACMR (target: $40). For income investors, CLPS offers the higher dividend yield at 14.60% vs ACMR's 0.19%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | — | Buy |
| Price TargetConsensus 12-month target | — | — | $14.00 | — | $40.00 |
| # AnalystsCovering analysts | — | — | 1 | — | 10 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +14.6% | +0.2% |
| Dividend StreakConsecutive years of raises | — | — | 0 | 3 | 3 |
| Dividend / ShareAnnual DPS | — | — | — | $0.13 | $0.11 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | +0.2% |
CODA leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). IZM leads in 1 (Valuation Metrics). 1 tied.
IZM vs LIQT vs CODA vs CLPS vs ACMR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IZM or LIQT or CODA or CLPS or ACMR a better buy right now?
For growth investors, Coda Octopus Group, Inc.
(CODA) is the stronger pick with 30. 7% revenue growth year-over-year, versus -17. 0% for ICZOOM Group Inc. (IZM). Coda Octopus Group, Inc. (CODA) offers the better valuation at 32. 2x trailing P/E (22. 5x forward), making it the more compelling value choice. Analysts rate Coda Octopus Group, Inc. (CODA) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IZM or LIQT or CODA or CLPS or ACMR?
On trailing P/E, Coda Octopus Group, Inc.
(CODA) is the cheapest at 32. 2x versus ACM Research, Inc. at 43. 2x. On forward P/E, Coda Octopus Group, Inc. is actually cheaper at 22. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ACM Research, Inc. wins at 0. 84x versus Coda Octopus Group, Inc. 's 5. 24x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — IZM or LIQT or CODA or CLPS or ACMR?
Over the past 5 years, ACM Research, Inc.
(ACMR) delivered a total return of +133. 4%, compared to -96. 1% for LiqTech International, Inc. (LIQT). Over 10 years, the gap is even starker: ACMR returned +30. 7% versus LIQT's -90. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IZM or LIQT or CODA or CLPS or ACMR?
By beta (market sensitivity over 5 years), ICZOOM Group Inc.
(IZM) is the lower-risk stock at -0. 74β versus ACM Research, Inc. 's 3. 24β — meaning ACMR is approximately -540% more volatile than IZM relative to the S&P 500. On balance sheet safety, Coda Octopus Group, Inc. (CODA) carries a lower debt/equity ratio of 1% versus 117% for LiqTech International, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IZM or LIQT or CODA or CLPS or ACMR?
By revenue growth (latest reported year), Coda Octopus Group, Inc.
(CODA) is pulling ahead at 30. 7% versus -17. 0% for ICZOOM Group Inc. (IZM). On earnings-per-share growth, the picture is similar: LiqTech International, Inc. grew EPS 45. 7% year-over-year, compared to -229. 4% for ICZOOM Group Inc.. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IZM or LIQT or CODA or CLPS or ACMR?
Coda Octopus Group, Inc.
(CODA) is the more profitable company, earning 15. 5% net margin versus -51. 7% for LiqTech International, Inc. — meaning it keeps 15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CODA leads at 17. 1% versus -50. 3% for LIQT. At the gross margin level — before operating expenses — CODA leads at 66. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IZM or LIQT or CODA or CLPS or ACMR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ACM Research, Inc. (ACMR) is the more undervalued stock at a PEG of 0. 84x versus Coda Octopus Group, Inc. 's 5. 24x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Coda Octopus Group, Inc. (CODA) trades at 22. 5x forward P/E versus 29. 7x for ACM Research, Inc. — 7. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CODA: 17. 6% to $14. 00.
08Which pays a better dividend — IZM or LIQT or CODA or CLPS or ACMR?
In this comparison, CLPS (14.
6% yield), ACMR (0. 2% yield) pay a dividend. IZM, LIQT, CODA do not pay a meaningful dividend and should not be held primarily for income.
09Is IZM or LIQT or CODA or CLPS or ACMR better for a retirement portfolio?
For long-horizon retirement investors, ICZOOM Group Inc.
(IZM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 74)). ACM Research, Inc. (ACMR) carries a higher beta of 3. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IZM: -88. 4%, ACMR: +30. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IZM and LIQT and CODA and CLPS and ACMR?
These companies operate in different sectors (IZM (Technology) and LIQT (Industrials) and CODA (Industrials) and CLPS (Technology) and ACMR (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: IZM is a small-cap quality compounder stock; LIQT is a small-cap quality compounder stock; CODA is a small-cap high-growth stock; CLPS is a small-cap high-growth stock; ACMR is a small-cap high-growth stock. CLPS pays a dividend while IZM, LIQT, CODA, ACMR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.